搜索
美敦力
MDT添加自选
82.350USD
-0.940-1.13%
收盘 07/21, 16:00（美东）报价延迟15分钟
105.69B总市值
22.89市盈率 TTM
关于 美敦力 公司
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
美敦力简介
公司代码MDT
公司名称Medtronic PLC
上市日期Nov 21, 1977
CEOMartha (Geoffrey S)
员工数量95000
证券类型Ordinary Share
年结日Nov 21
公司地址Building Two Parkmore Business Park West
城市DUBLIN
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家Ireland
邮编H91 4K49
电话1135314381700
网址https://www.medtronic.com/
公司代码MDT
上市日期Nov 21, 1977
CEOMartha (Geoffrey S)
美敦力公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.95M
-2.15%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
575.08K
+4.68%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
59.78K
-12.50%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.77%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
50.75K
+3.75%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
42.14K
+4.52%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
23.61K
+8.06%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
19.54K
+9.74%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
10.10K
+18.86%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Independent Director
Independent Director
7.63K
+24.97%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.95M
-2.15%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
575.08K
+4.68%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
59.78K
-12.50%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.77%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
50.75K
+3.75%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
42.14K
+4.52%
常见问题
美敦力的前五大股东是谁？
美敦力 的前五大股东如下：Mr. Geoffrey S. (Geoff) Martha
有多少机构持有美敦力(MDT)的股份？
截至2026Q1，共有3854家机构持有美敦力的股份，合计持有的股份价值约为1.12B，占公司总股份的86.90%。与2025Q4相比，机构持股有所增加，增幅为-35115160.00。
哪个业务部门对美敦力的收入贡献最大？
在2026Q1，Cardiac Rhythm & Heart Failure业务部门对美敦力的收入贡献最大，创收1.86B，占总收入的20.58%。